Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00518531
Status:
COMPLETED
Last Update Posted:
2019-12-03
First Post:
2007-08-16
Brief Title:
Denosumab Adherence Preference Satisfaction Study
Sponsor:
Amgen
Organization:
Amgen
Study Overview
Official Title:
A Multicenter Randomized Cross-Over Open-label Study to Evaluate the Adherence Preference and Satisfaction of Denosumab and Alendronate in Postmenopausal Women With Low Bone Mineral Density
Status:
COMPLETED
Status Verified Date:
2019-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective is to evaluate the adherence of subjects to subcutaneous SC 60 mg denosumab every 6 months Q6M treatment compared to oral 70 mg alendronate once a week QW treatment at the end of treatment period 1 12 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DAPS | None | None | None |